NIPH Clinical Trials Search

Basic Information

Recruitment status	terminated
Health condition(s) or Problem(s) studied
Date of first enrollment	31/12/2020
Target sample size	8
Countries of recruitment	Japan,North America,Europe
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : INN of investigational material : - Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : Generic name etc : INN of investigational material : spartalizumab Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : gemcitabine Therapeutic category code : 422 Antimetabolic agents Dosage and Administration for Investigational material : Generic name etc : INN of investigational material : nab-paclitaxel Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material :

Outcome(s)

Primary Outcome	safety efficacy
Secondary Outcome	safety efficacy exploratory pharmacokinetics

Key inclusion & exclusion criteria

Age minimum	>= 18age old
Age maximum	Not applicable
Gender	Both
Include criteria
Exclude criteria